tiprankstipranks

Charles Newhall Insider Profile

4 Followers
Charles Newhall, Director at Supernus Pharmaceuticals, holds 97.51K shares in Supernus Pharmaceuticals (Ticker: SUPN), holds 289.00 shares in Vitae Pharma (Ticker: VTAE), holds 2.88M shares in Hyperion Therapeutics (Ticker: HPTX).
tipranks
Charles Newhall

Charles Newhall
Supernus Pharmaceuticals (SUPN)
Director

Ranked #2,331 out of 78,624 Corporate Insiders

Profitable Transactions

36%
4 out of 11 Profitable Transactions

Average Return

+46.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3B
90.10%
5.06%
3.46%
0.88%
0.50% Others
A breakdown of Charles Newhall's holdings

Insider Roles

Groupon
(GRPN)
Ten Percent Owner
DZS
(DZSI)
Ten Percent Owner
Amicus
(FOLD)
Ten Percent Owner
Catalyst Biosciences
(CBIO)
Ten Percent Owner
+5 other positions
Roles that Charles Newhall holds in companies

Most Profitable Insider Trade

Stock:
Groupon
(GRPN)
Rating:Informative Buy
Date:Nov 03, 2011 - Nov 03, 2012
Return:+283.00%
The most profitable trade made by Charles Newhall

Charles Newhall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Supernus Pharmaceuticals
Feb 25, 2020
Director
Uninformative Buy
125.01K
$2.13M
VTAE
Vitae Pharma
Jul 02, 2015
Uninformative Buy
$6.07K
Groupon
Nov 03, 2011
Ten Percent Owner
Informative Buy
$2.78B
FNGN
Financial Engines
Sep 01, 2010
Uninformative Sell
$156.51M
Amicus
Mar 09, 2012
Ten Percent Owner
Informative Buy
6.50M
$106.54M
Catalyst Biosciences
Ten Percent Owner
$27.16M
Ten Percent Owner
$155.95M
Vonage Holdings
Mar 15, 2011
Ten Percent Owner
Uninformative Buy
$294.71K
INWK
InnerWorkings
Mar 30, 2012
Uninformative Buy
$44.85K
Echo Global Logistics
Mar 01, 2012
Ten Percent Owner
Uninformative Buy
$2.80K
FIO
Fusion-IO
Jun 07, 2011
Informative Buy
Paratek Pharmaceuticals
Feb 03, 2009
Ten Percent Owner
Uninformative Buy
$12.92M
Workday
Ten Percent Owner
$0.00
HPTX
Hyperion Therapeutics
Aug 02, 2012
Uninformative Buy
9.47M
ARDMQ
Aradigm
$0.00
List of latest transactions for each holding click on a transaction to see Charles Newhall's performance on stock

Charles Newhall insider profile FAQ

What is the percentage of profitable transactions made by Charles Newhall?
The percentage of profitable transactions made by Charles Newhall is 36%.
    What is the average return per transaction made by Charles Newhall?
    The average return per transaction made by Charles Newhall is 46.90%.
      What stocks does Charles Newhall hold?
      Charles Newhall holds: SUPN, VTAE, GRPN, FNGN, FOLD, CBIO, DZSI, VG, INWK, ECHO, FIO, PRTK, WDAY, HPTX, ARDMQ stocks.
        What was Charles Newhall’s latest transaction?
        Charles Newhall latest transaction was an Uninformative Buy of $125.01K.
          What was Charles Newhall's most profitable transaction?
          Charles Newhall’s most profitable transaction was an Informative Buy of GRPN stock on November 3, 2011. The return on the trade was 283.00%.
            What is Charles Newhall's role in Supernus Pharmaceuticals?
            Charles Newhall's role in Supernus Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.